RS
Raghuram Selvaraju HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Emergent Biosolutions
EBS
$407M
| $7.63 | $15 |
97%
upside
| Buy | yesterday |
|
2
BridgeBio Pharma
BBIO
$9.91B
| $51.83 | $70 |
35%
upside
| Buy | yesterday |
|
3
Repligen
RGEN
$6.78B
| $120.58 | $180 |
49%
upside
| Buy | yesterday |
|
|
BWAY
4
Brainsway
BWAY
$302M
| $15.97 | $17 |
6%
upside
| Buy | 10 days ago |
|
5
Anavex Life Sciences
AVXL
$804M
| $9.36 | $42 |
349%
upside
| Buy | 13 days ago |
|
|
SEPN
6
Septerna, Inc. Common Stock
SEPN
$630M
| $14.12 | $26 |
84%
upside
| Buy | 14 days ago |
|
7
Fennec Pharmaceuticals
FENC
$255M
| $9.18 | $13 |
42%
upside
| Buy | 14 days ago |
|
8
Vanda Pharmaceuticals
VNDA
$274M
| $4.64 | $20 |
331%
upside
| Buy | 14 days ago |
|
9
Abeona Therapeutics
ABEO
$352M
| $6.86 | $20 |
192%
upside
| Buy | 17 days ago |
|
10
Soleno Therapeutics
SLNO
$3.7B
| $69.57 | $110 |
58%
upside
| Buy | 17 days ago |
|
11
Genmab
GMAB
$16.8B
| $27.38 | $36 |
31%
upside
| Buy | 20 days ago |
|
12
Innoviva
INVA
$1.32B
| $20.92 | $45 |
115%
upside
| Buy | 24 days ago |
|
|
NAGE
13
Niagen Bioscience, Inc. Common Stock
NAGE
$743M
| $9.32 | $12 |
29%
upside
| Buy | 24 days ago |
|
14
UroGen Pharma
URGN
$870M
| $18.80 | $40 |
113%
upside
| Buy | 24 days ago |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.46B
| $14.99 | $24 |
60%
upside
| Buy | 27 days ago |
|
16
Rhythm Pharmaceuticals
RYTM
$6.95B
| $104.57 | $100 |
4%
downside
| Buy | 28 days ago |
|
|
BCPC
17
Balchem Corporation
BCPC
$5.24B
| $161.40 | $189 |
17%
upside
| Buy | 1 month ago |
|
18
Ultragenyx Pharmaceutical
RARE
$3.01B
| $31.28 | $80 |
156%
upside
| Buy | 1 month ago |
|
|
VRNA
19
Verona Pharma
VRNA
$9.19B
| $106.24 | $107 |
1%
upside
| Neutral | 1 month ago |
|
20
Aquestive Therapeutics
AQST
$612M
| $5.06 | $10 |
98%
upside
| Buy | 2 months ago |
|
21
Omeros
OMER
$284M
| $4.18 | $9 |
115%
upside
| Buy | 2 months ago |
|
22
Axsome Therapeutics
AXSM
$6.21B
| $124.41 | $180 |
45%
upside
| Buy | 2 months ago |
|
23
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $40 |
117%
upside
| Neutral | 3 months ago |
|
24
Benitec Biopharma
BNTC
$368M
| $14 | $28 |
100%
upside
| Buy | 3 months ago |
|
25
Regenxbio
RGNX
$476M
| $9.42 | $34 |
261%
upside
| Buy | 5 months ago |
|